MB, Levis & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Buy |
14,032
+403
| +3% | +$31.9K | 0.49% | 34 |
|
|
2025
Q1 | $1.22M | Buy |
13,629
+101
| +0.7% | +$9.07K | 0.57% | 32 |
|
|
2024
Q4 | $1.35M | Buy |
13,528
+75
| +0.6% | +$7.46K | 0.67% | 27 |
|
|
2024
Q3 | $1.53M | Buy |
13,453
+31
| +0.2% | +$3.52K | 0.75% | 23 |
|
|
2024
Q2 | $1.66M | Buy |
13,422
+20
| +0.1% | +$2.48K | 0.87% | 22 |
|
|
2024
Q1 | $1.77M | Buy |
13,402
+42
| +0.3% | +$5.54K | 0.95% | 22 |
|
|
2023
Q4 | $1.46M | Buy |
13,360
+98
| +0.7% | +$10.7K | 0.83% | 22 |
|
|
2023
Q3 | $1.37M | Sell |
13,262
-72
| -0.5% | -$7.41K | 0.89% | 22 |
|
|
2023
Q2 | $1.54M | Buy |
13,334
+39
| +0.3% | +$4.5K | 0.99% | 21 |
|
|
2023
Q1 | $1.41M | Sell |
13,295
-47
| -0.4% | -$5K | 0.98% | 22 |
|
|
2022
Q4 | $1.48M | Buy |
+13,342
| New | +$1.48M | 1.16% | 21 |
|